insert into donations(donor, donee, amount, donation_date, donation_date_precision, donation_date_basis, cause_area, url, influencer, goal_amount, fraction, affected_countries, donation_earmark, donation_announcement_date, donation_announcement_date_precision, donation_announcement_url, donation_process, intended_use_of_funds_category, intended_use_of_funds, intended_funding_timeframe_in_months, donor_donee_reason, donor_amount_reason, donor_timing_reason, donor_next_donation_thoughts, donor_retrospective, notes) values
  ('GiveWell Maximum Impact Fund','Malaria Consortium',8400000,'2019-03-01','month','donation log','Global health/malaria/seasonal malaria chemoprevention','https://www.givewell.org/maximum-impact-fund','GiveWell',8400000,1.0,'Burkina Faso|Nigeria|Chad',NULL,'2019-03-29','day','ttps://blog.givewell.org/2019/03/29/allocation-of-discretionary-funds-from-q4-2018/',
  /* donation_process */ 'GiveWell looked at the funding gap and value of marginal funds for each of its top charities. Two charities that competed closely for the discretionary regrant were Malaria Consortium and Against Malaria Foundation. The blog post https://blog.givewell.org/2019/03/29/allocation-of-discretionary-funds-from-q4-2018/ has a lengthy section "Comparing Malaria Consortium and AMF" that applies the six principles in https://blog.givewell.org/2018/11/26/our-recommendation-to-good-ventures/#Principles to compare the two options, ultimately deciding on allocating 100% to Malaria Consortium',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'Malaria Consortium expects to use the funding (earmarked for seasonal malaria chemoprevention) on these projects, in decreasing order of priority: (1) Contribute to filling a potential funding gap in Burkina Faso, (2) Scale up further in Nigeria and Chad in 2020, (3) Fund the continuation of programs into 2021.',
  /* intended_funding_timeframe_in_months */ NULL,
  /* donor_donee_reason */ 'Malaria Consortium is operating in a domain, seasonal malaria chemprevention, that GiveWell considers highly cost-effective, and is estimated at delivering 8.3x as much value per unit money as cash transfers. Reasons for selecting Malaria Consortium over the Against Malaria Foundation include: stronger organizational management at Malaria Consortium, and more cooperation from Malaria Consortium in helping with GiveWell''s evaluation process',
  /* donor_amount_reason */ 'The amount of $8.4 million includes $7.6 million in discretionary funds directly available to GiveWell for regranting, and an additiona $0.8 million held by the Centre for Effective Altruism on its behalf. $1.7 million from the Effective Altruism Funds (Global Health and Development Fund) is also allocated to Malaria Consortium along with this $8.4 million',
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q4 2018 (September to December) and would therefore be expected to be in Q1 2019. The discretionary regranting is relatively delayed compared to normal (it is usually completed within two months after the end of the quarter). The reason for the delay is likely that GiveWell waited for the end-of-year giving season to finish in order to better assess the remaining room for more funding. The amount is also larger than the amounts regranted in other quarters, reflecting more giving in Q4 in general.',
  /* donor_next_donation_thoughts */ NULL,
  /* donot_retrospective */ 'Although not an explicit retrospective, the blog post discussing the next GiveWell discretionary regrant https://blog.givewell.org/2019/06/12/allocation-of-discretionary-funds-from-q1-2019/ describes some of GiveWell''s updated thinking about the same problem.',
  /* notes */ NULL),

  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',4700000,'2019-06-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','GiveWell',4700000,1.0,'Democratic Republic of the Congo',NULL,'2019-06-12','day','https://blog.givewell.org/2019/06/12/allocation-of-discretionary-funds-from-q1-2019/',
  /* donation_process */ 'GiveWell looked at the funding gap and value of marginal funds for each of its top charities. Two charities that competed closely for the discretionary regrant were Malaria Consortium and Against Malaria Foundation. The blog post https://blog.givewell.org/2019/06/12/allocation-of-discretionary-funds-from-q1-2019/ has a section "Our process" describing how GiveWell decided to support AMF instead of Malaria Consortium.',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'AMF expects to allocate all funding that it receives in the near future toward distributing insecticide-treated nets in the Democratic Republic of Congo (DRC) in 2020. More is explained in https://blog.givewell.org/2019/06/12/allocation-of-discretionary-funds-from-q1-2019/ in the "What AMF will do with additional funding" section.',
  /* intended_funding_timeframe_in_months */ NULL,
  /* donor_donee_reason */ 'In the section "Updates since March 2019" of the blog post https://blog.givewell.org/2019/06/12/allocation-of-discretionary-funds-from-q1-2019/ GiveWell explains why it selected AMF instead of Malaria Consortium for this discretionary regrant, even though the previous quarter, it had selected MC. The two main reasons listed are: (1) An error correction in the cost-effectiveness estimate for AMF, described at https://www.givewell.org/how-we-work/our-criteria/cost-effectiveness/cost-effectiveness-models/changelog-2019#Version_3_Published_March_21_2019 has increased GiveWell''s cost-effectiveness estimate for AMF, (2) After the previous quarter''s discretionary regrant to MC in March 2019 described at https://blog.givewell.org/2019/03/29/allocation-of-discretionary-funds-from-q4-2018/ GiveWell thinks MC has less room for more funding.',
  /* donor_amount_reason */ 'The amount is the amount donated by donors to GiveWell for discretionary regranting to top charities in Q1 2019; GiveWell allocates the money separately for each quarter',
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q1 2019 (January to March) and would therefore be expected to be in Q2 2019, which it is.',
  /* donor_next_donation_thoughts */ NULL,
  /* donor_retrospective */ NULL,
  /* notes */ NULL),

  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',2300000,'2019-08-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','GiveWell',2300000,1.0,'Democratic Republic of the Congo',NULL,'2019-08-21','day','https://blog.givewell.org/2019/08/21/allocation-of-discretionary-funds-from-q2-2019/',
  /* donation_process */ 'GiveWell looked at the funding gap and value of marginal funds for each of its top charities. Two charities that competed closely for the discretionary regrant were Malaria Consortium and Against Malaria Foundation. The blog post https://blog.givewell.org/2019/08/21/allocation-of-discretionary-funds-from-q2-2019/ goes over the comparison with Malaria Consortium, and has a section "Process for deciding where to allocate fund" describing the process and linking to a previous post https://blog.givewell.org/2018/11/26/our-recommendation-to-good-ventures/#Principles for more information',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'AMF will use additional funding to support a distribution of nets scheduled for 2020 in the Democratic Republic of the Congo (DRC) in 2020 or 2021. https://blog.givewell.org/2019/08/21/allocation-of-discretionary-funds-from-q2-2019/#AdditionalFunding has more details.',
  /* intended_funding_timeframe_in_months */ NULL,
  /* donor_donee_reason */ 'The section https://blog.givewell.org/2019/08/21/allocation-of-discretionary-funds-from-q2-2019/#OtherPossibilities says: "Weighing these factors, we ultimately chose AMF over Malaria Consortium based on its somewhat higher modeled cost-effectiveness and more time-sensitive funding need." This is the same decision made for allocating the previous quarter''s discretionary funds, as described at https://blog.givewell.org/2019/06/12/allocation-of-discretionary-funds-from-q1-2019/',
  /* donor_amount_reason */ 'The amount is the amount donated by donors to GiveWell for discretionary regranting to top charities in Q2 2019; GiveWell allocates the money separately for each quarter',
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q2 2019 (April to June) and would therefore be expected to be in Q3 2019, which it is.',
  /* donor_next_donation_thoughts */ 'The section https://blog.givewell.org/2019/08/21/allocation-of-discretionary-funds-from-q2-2019/#OtherPossibilities says: "We now model additional funding to AMF as roughly 33 percent more cost-effective than additional funding to Malaria Consortium’s SMC program, as a result of adjusting the chance of additional funding supporting nets in DRC from 87 percent to 75 percent. We have not received any new information to update us on the time sensitivity of Malaria Consortium’s funding needs, and we continue to view Malaria Consortium as stronger than AMF on unmodeled qualitative factors."',
  /* donor_retrospective */ NULL,
  /* notes */ NULL),

  ('GiveWell Maximum Impact Fund','Helen Keller International',2600000,'2019-12-01','month','donation log','Global health/nutrition/vitamin A supplementation','https://www.givewell.org/maximum-impact-fund','GiveWell',2600000,1.0,'Guinea|Mali|Burkina Faso|Côte d''Ivoire|Niger|Democratic Republic of the Congo|Nigeria',NULL,'2019-12-19','day','https://blog.givewell.org/2019/12/19/allocation-of-discretionary-funds-from-q3-2019/',
  /* donation_process */ 'GiveWell looked at the funding gap and value of marginal funds for each of its top charities. The decision to allocate these funds happened shortly after the annual top charity refresh and the updated recommendations https://www.givewell.org/charities/top-charities/2019/open-philanthropy-recommendation#Our_recommended_allocation_to_Open_Philanthropy to Good Ventures (via Open Philanthropy) on how much annual support to give to each top charity. It therefore took into account the amounts already recommended to Open Philanthropy, and calculated the best use of funds at the margin after that. The main competing charity for this grant was Sightsavers (deworming).',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'Grant to support the vitamin A supplementation (VAS) program, which has GiveWell top charity status. https://www.givewell.org/charities/top-charities/2019/open-philanthropy-recommendation#Helen_Keller_International-s_VAS_program gives the expected allocation of this money plus $9.7 million from Open Philanthropy: "$5.5 million to continue its work in five countries (Guinea, Mali, Burkina Faso, Côte d''Ivoire, and Niger), including supplementing its budgets in 2020 and 2021 and extending its funding runway to 2022. Cost-effectiveness: 31x cash, $4.5 million to start a new program in the Democratic Republic of Congo (DRC), with funding to cover 2020-2022. Cost-effectiveness: 27x cash, $2.4 million to expand its program to Bauchi State, Nigeria, with funding to cover 2020-2022. Cost-effectiveness: 25x cash."',
  /* intended_funding_timeframe_in_months */ NULL,
  /* donor_donee_reason */ 'According to https://blog.givewell.org/2019/12/19/allocation-of-discretionary-funds-from-q3-2019/#OurProcess "The first of these principles is to put significant weight on our cost-effectiveness estimates, which aim to capture total improvement in well-being per dollar spent. These estimates suggested that HKI’s VAS program had a very high priority funding gap (28x cash overall in the seven countries listed above)." The reason to select this instead of Sightsavers'' deworming program: "we were considering changes to our deworming cost-effectiveness model and were uncertain whether we would estimate Sightsavers’ cost-effectiveness as higher or lower than HKI’s."',
  /* donor_amount_reason */ 'The amount is the amount donated by donors to GiveWell for discretionary regranting to top charities in Q3 2019; GiveWell allocates the money separately for each quarter.',
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q3 2019 (July to September) and would therefore be expected to be in Q4 2019, which it is.',
  /* donor_next_donation_thoughts */ 'https://blog.givewell.org/2019/12/19/allocation-of-discretionary-funds-from-q3-2019/#BottomLine says: "We believe that Malaria Consortium’s program has the highest impact per additional dollar donated today. After the Open Philanthropy grant and the Q3 discretionary funding, additional donations to HKI’s VAS program would support funding gaps that we model as less cost-effective than the funding gaps on Malaria Consortium’s current margin."',
  /* donor_retrospective */ 'The next round https://blog.givewell.org/2020/03/17/allocation-of-discretionary-funds-from-q4-2019/ would grant a furtheer $1.5 million to Helen Keller International''s program, and consider the funding gap closed with the grant.',
  /* notes */ NULL),

  ('GiveWell Maximum Impact Fund','Helen Keller International',1500000,'2020-03-01','month','donation log','Global health/nutrition/vitamin A supplementation','https://www.givewell.org/maximum-impact-fund','GiveWell',13400000,0.1119,'Côte d’Ivoire',NULL,'2020-03-17','day','https://blog.givewell.org/2020/03/17/allocation-of-discretionary-funds-from-q4-2019/',
  /* donation_process */ 'According to https://blog.givewell.org/2020/03/17/allocation-of-discretionary-funds-from-q4-2019/#allocationprocess "We decide how to allocate discretionary funds by reviewing which of our top charities’ unmet funding needs, or “funding gaps,” are the most cost-effective and time-sensitive. In January 2020, we asked HKI, Malaria Consortium, and SCI Foundation (SCI) for updates on their funding needs. [...] We did not request updated funding information from our other five top charities. [...] We were not informed of any opportunities this quarter outside of the information we received from HKI, Malaria Consortium, and SCI."',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'Grant to support the vitamin A supplementation (VAS) program, which has GiveWell top charity status.',
  /* intended_funding_timeframe_in_months */ 34,
  /* donor_donee_reason */ 'https://blog.givewell.org/2020/03/17/allocation-of-discretionary-funds-from-q4-2019/#hki says: "In 2019, HKI told us that it did not expect Global Affairs Canada (GAC) to renew its support for VAS programs in Côte d’Ivoire and Kenya from 2020 onward. HKI confirmed in January 2020 that GAC had not renewed its funding. We consider HKI’s VAS program in Côte d’Ivoire to be highly cost-effective. Our top priority for fourth-quarter discretionary funds is filling the $1.5 million funding gap left by GAC in Côte d’Ivoire from 2020 to 2022."',
  /* donor_amount_reason */ 'The funding gap for Côte d’Ivoire is $1.5 million, and is the highest-priority funding gap identified. Since the total funds available of $13.4 million are in excess of this funding gap, the entire funding gap is filled by the grant.',
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q4 2019 (October to December) and would therefore be expected to be in Q1 2020, which it is.',
  /* donor_next_donation_thoughts */ 'Since this grant fills the highest-priority funding gaps, there are no immediate plans for further grants.',
  /* donor_retrospective */ 'The next grants from the Maximum Impact Fund to Helen Keller International would be for Q1 2021; see https://www.givewell.org/maximum-impact-fund/allocation-q1-2021 for details. This would be for different countriees.',
  /* notes */ 'https://blog.givewell.org/2020/03/17/allocation-of-discretionary-funds-from-q4-2019/#uncertainties discusses some uncertainties. For HKI: "We don’t know whether, in the absence of a GiveWell grant to HKI, VAS campaigns in the districts formerly funded by GAC would be skipped or if HKI would reallocate other available funding to support these campaigns. Reallocation of HKI’s available funding would make its funding gap in Côte d’Ivoire less time-sensitive but would leave funding gaps for other work in a year or two. These new gaps would be our top priority to fill due to their high cost-effectiveness. We haven’t resolved this question because we believe our discretionary grant to HKI will support the most cost-effective unfunded work we are aware of, regardless of time-sensitivity."'),

  ('GiveWell Maximum Impact Fund','Malaria Consortium',11900000,'2020-03-01','month','donation log','Global health/malaria/seasonal malaria chemoprevention','https://www.givewell.org/maximum-impact-fund','GiveWell',13400000,0.88,NULL,NULL,'2020-03-17','day','https://blog.givewell.org/2020/03/17/allocation-of-discretionary-funds-from-q4-2019/',
  /* donation_process */ 'According to https://blog.givewell.org/2020/03/17/allocation-of-discretionary-funds-from-q4-2019/#allocationprocess "We decide how to allocate discretionary funds by reviewing which of our top charities’ unmet funding needs, or “funding gaps,” are the most cost-effective and time-sensitive. In January 2020, we asked HKI, Malaria Consortium, and SCI Foundation (SCI) for updates on their funding needs. [...] We did not request updated funding information from our other five top charities. [...] We were not informed of any opportunities this quarter outside of the information we received from HKI, Malaria Consortium, and SCI."',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'Grant for the seasonal malaria chemoprevention (SMC) program. https://blog.givewell.org/2020/03/17/allocation-of-discretionary-funds-from-q4-2019/#malariaconsortium says: "We estimate that Malaria Consortium can now effectively absorb approximately $36 million for SMC programs in 2022 in Burkina Faso, Chad, Nigeria, and Togo. [...] We allocated the remaining $11.9 million in fourth-quarter discretionary funds to Malaria Consortium’s SMC program as our second priority."',
  /* intended_funding_timeframe_in_months */ NULL,
  /* donor_donee_reason */ 'According to https://blog.givewell.org/2020/03/17/allocation-of-discretionary-funds-from-q4-2019/ the Malaria Consortium SMC program was identified as the second highest priority of three programs considered for this round of funding, behind Helen Keller International''s Vitamin A supplementation but ahead of SCI. Since the funding gap for HKI''s priority program of $1.5 million was well under the $13.4 million in allocatable funds, all the remainder of the funding was granted to Malaria Consortium.',
  /* donor_amount_reason */ 'A total of $13.4 million from Q4 2019 was available for granting in this round, of which $1.5 million was allocated to the higher-priority Helen Keller International Vitamin A supplementation program. Since the remainder of $11.9 million was much less than the $36 million in funds that GiveWell believed Malaria Consortium could absorb, the entirely of that remainder was allocated to Malaria Consortium. The amount of $13.4 million was higher than in most quarters, partly because Q4 in general sees more giving, and partly because of increased emphasis by GiveWell on donating to the Maximum Impact Fund rather than directly to top charities.',
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q4 2019 (October to December) and would therefore be expected to be in Q1 2020, which it is.',
  /* donor_next_donation_thoughts */ 'While further grants are not explicitly discussed, the fact that a significant funding gap remains for Malaria Consortium''s SMC program ($36 million - $11.9 million = $24.1 million), future rounds are likely to include grants to the program barring new information.',
  /* donor_retrospective */ 'The next grant from the Maximum Impact Fund would end up selecting Against Malaria Foundation due to some new information, but Malaria Consortium would receive funding in https://www.givewell.org/sources/blog-post/our-recommendations-for-giving-in-2020#2 for Q3 2020.',
  /* notes */ 'https://blog.givewell.org/2020/03/17/allocation-of-discretionary-funds-from-q4-2019/#uncertainties discusses uncertainties. For this grant: "It is possible that other funders will also step in to fill some of this gap. In particular, we believe that one funder that supported SMC coverage in part of Burkina Faso in 2020 may choose to extend its support through 2022; this would decrease Malaria Consortium’s room for more funding by around $8 million. Even if this occurs, Malaria Consortium would still have a significant unfilled gap ($16.1 million) for its work in 2022."'),

  ('GiveWell flexible funding','Malaria Consortium',8000000,'2020-06-01','month','donation log','Global health/malaria/seasonal malaria chemoprevention','https://www.givewell.org/maximum-impact-fund','GiveWell',8000000,1.0,NULL,NULL,'2020-10-13','day','https://blog.givewell.org/2020/10/13/maximum-impact-fund-update-we-estimate-givewell-donors-15-3-million-to-the-against-malaria-foundation-will-save-over-3000-lives/',
  /* donation_process */ 'This funding comes from a flexible funding $8 million grant from a donor that is partially restricted to GiveWell’s “top life improving nonprofit/s,” as first mentioned in https://blog.givewell.org/2020/03/17/allocation-of-discretionary-funds-from-q4-2019/ (2020-03-17) at which time GiveWell is considering making that grant to SCI.',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'Grant for the seasonal malaria chemoprevention (SMC) program. After a $11.9 million grant made in March 2020 using Q4 2019 funds, a remaining funding gap of ~$24 million remained; this $8 million goes toward closing that funding gap.',
  /* intended_funding_timeframe_in_months */ NULL,
  /* donor_donee_reason */ 'The reasons are likely similar to the reasons outlined in https://blog.givewell.org/2020/03/17/allocation-of-discretionary-funds-from-q4-2019/ for the previous grant from the Maximum Impact Fund: the Malaria Consortium SMC program was identified as the second highest priority of three programs considered for this round of funding, behind Helen Keller International''s Vitamin A supplementation but ahead of SCI. Since the funding gap for HKI''s priority program of $1.5 million was well under the $13.4 million in allocatable funds, all the remainder of the funding was granted to Malaria Consortium.',
  /* donor_amount_reason */ 'The amount is precisely the amount that the donor of the flexible funds provided.',
  /* donor_timing_reason */ 'According to https://www.givewell.org/sources/blog-post/q1-q2-2020-discretionary-funding-allocation#10 "The donor requested that we grant the funds immediately, rather than holding them to disburse with "Grants to recommended charities at GiveWell''s discretion." We selected Malaria Consortium for the high cost-effectiveness of its planned work."',
  /* donor_next_donation_thoughts */ NULL,
  /* donor_retrospective */ 'https://www.givewell.org/sources/blog-post/q1-q2-2020-discretionary-funding-allocation#10 says: "Taking the $8 million into account, we saw Malaria Consortium''s remaining funding needs as less time-sensitive than AMF''s when we considered granting the other flexible funds we received in the first half of 2020."',
  /* notes */ 'Although this grant is listed and discussed along with grants from the GiveWell Maximum Impact Fund, the grant itself is not from the Maximum Impact Fund.'),

  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',11700000,'2020-09-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','GiveWell',11700000,1.0,'Democratic Republic of the Congo|Guinea',NULL,'2020-10-13','day','https://blog.givewell.org/2020/10/13/maximum-impact-fund-update-we-estimate-givewell-donors-15-3-million-to-the-against-malaria-foundation-will-save-over-3000-lives/',
  /* donation_process */ 'https://blog.givewell.org/2020/10/13/maximum-impact-fund-update-we-estimate-givewell-donors-15-3-million-to-the-against-malaria-foundation-will-save-over-3000-lives/ says: "We typically allocate flexible donations to our top charities every quarter. However, we delayed allocating the donations we received to “Grants to recommended charities at GiveWell’s discretion” in the first quarter of 2020. We wanted to better understand the impact of the growing COVID-19 pandemic on charities’ budgets and plans before making a decision about where funding would have the greatest impact. [...] We considered making grants to Malaria Consortium’s seasonal malaria chemoprevention (SMC) program and Helen Keller International (HKI)’s vitamin A supplementation program, as we estimated that they were similarly cost-effective to AMF when we began our decisionmaking process."',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'https://blog.givewell.org/2020/10/13/maximum-impact-fund-update-we-estimate-givewell-donors-15-3-million-to-the-against-malaria-foundation-will-save-over-3000-lives/ says: "AMF supports the distribution of insecticide-treated nets in areas with high rates of malaria. The nets stop mosquitoes from biting and spreading the disease. We estimate our donors’ support for AMF will collectively save over 3,000 lives, mostly of young children in the Democratic Republic of the Congo (DRC) and Guinea. Without this grant, we think net distributions in DRC and Guinea would have been delayed."',
  /* intended_funding_timeframe_in_months */ NULL,
  /* donor_donee_reason */ 'https://blog.givewell.org/2020/10/13/maximum-impact-fund-update-we-estimate-givewell-donors-15-3-million-to-the-against-malaria-foundation-will-save-over-3000-lives/ says: "AMF was a top contender for receiving this grant because of its high estimated impact per dollar. It is continuing its work during the pandemic, with some delays and modifications. [...] As of June 2020, AMF had committed nearly all of this [past $70 million] funding and held only around $4 million in uncommitted funds. [...] There is a strong case the distributions would be delayed without this grant, as funding needs to be secured well before nets are provided. [...] We investigated AMF’s current monitoring practices in detail this year and believe AMF meets our high standards. [...] our investigation into [Malaria Consortium SMC and Helen Keller International Vitamin A supplementation] current plans and budgets did not turn up urgent funding needs."',
  /* donor_amount_reason */ 'The entirety of funds available in the Maximum Impact Fund from Q1 and Q2 2020 was granted to Against Malaria Foundation, as it was the highest-priority funding need identified.',
  /* donor_timing_reason */ 'This grant round included allocation of funds for two quarters (Q1 and Q2 2020) in Q3 2020. https://blog.givewell.org/2020/10/13/maximum-impact-fund-update-we-estimate-givewell-donors-15-3-million-to-the-against-malaria-foundation-will-save-over-3000-lives/ explains the allocation delay: "We typically allocate flexible donations to our top charities every quarter. However, we delayed allocating the donations we received to “Grants to recommended charities at GiveWell’s discretion” in the first quarter of 2020. We wanted to better understand the impact of the growing COVID-19 pandemic on charities’ budgets and plans before making a decision about where funding would have the greatest impact."',
  /* donor_next_donation_thoughts */ NULL,
  /* donor_retrospective */ NULL,
  /* notes */ 'An additional $3.6 million in unrestricted funding available to GiveWell is also allocated to Against Malaria Foundation, bringing its total funding in this round to $15.3 million. In addition, GiveWell announces that it had granted $8 million in flexible funding to the Malaria Consortium''s SMC program in June.'),

  ('GiveWell unrestricted','Against Malaria Foundation',3600000,'2020-09-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','GiveWell',3600000,1.0,'Democratic Republic of the Congo|Guinea',NULL,'2020-10-13','day','https://blog.givewell.org/2020/10/13/maximum-impact-fund-update-we-estimate-givewell-donors-15-3-million-to-the-against-malaria-foundation-will-save-over-3000-lives/',
  /* donation_process */ 'This amount was granted along with the allocation of $11.7 million for Q1/Q2 2020 from the GiveWell Maximum Impact Fund, and the selection of grantees followed the same process.',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'https://blog.givewell.org/2020/10/13/maximum-impact-fund-update-we-estimate-givewell-donors-15-3-million-to-the-against-malaria-foundation-will-save-over-3000-lives/ says: "AMF supports the distribution of insecticide-treated nets in areas with high rates of malaria. The nets stop mosquitoes from biting and spreading the disease."',
  /* intended_funding_timeframe_in_months */ NULL,
  /* donor_donee_reason */ 'https://blog.givewell.org/2020/10/13/maximum-impact-fund-update-we-estimate-givewell-donors-15-3-million-to-the-against-malaria-foundation-will-save-over-3000-lives/ says: "AMF was a top contender for receiving this grant because of its high estimated impact per dollar. It is continuing its work during the pandemic, with some delays and modifications. [...] As of June 2020, AMF had committed nearly all of this [past $70 million] funding and held only around $4 million in uncommitted funds. [...] There is a strong case the distributions would be delayed without this grant, as funding needs to be secured well before nets are provided. [...] We investigated AMF’s current monitoring practices in detail this year and believe AMF meets our high standards. [...] our investigation into [Malaria Consortium SMC and Helen Keller International Vitamin A supplementation] current plans and budgets did not turn up urgent funding needs."',
  /* donor_amount_reason */ 'While the reasons for the amount are not discussed, it''s likely that this was the amount GiveWell could allocate of its unrestricted funding after making sure it had enouogh for its operating costs.',
  /* donor_timing_reason */ 'The grant is timed to be along with the grant from the Maximum Impact Fund. https://blog.givewell.org/2020/10/13/maximum-impact-fund-update-we-estimate-givewell-donors-15-3-million-to-the-against-malaria-foundation-will-save-over-3000-lives/ explains the allocation delay: "We typically allocate flexible donations to our top charities every quarter. However, we delayed allocating the donations we received to “Grants to recommended charities at GiveWell’s discretion” in the first quarter of 2020. We wanted to better understand the impact of the growing COVID-19 pandemic on charities’ budgets and plans before making a decision about where funding would have the greatest impact."',
  /* donor_next_donation_thoughts */ NULL,
  /* donor_retrospective */ NULL,
  /* notes */ NULL),

  ('GiveWell Maximum Impact Fund','Malaria Consortium',3800000,'2020-12-01','month','donation log','Global health/malaria/seasonal malaria chemoprevention','https://www.givewell.org/maximum-impact-fund','GiveWell',3800000,1.0,NULL,NULL,'2020-11-19','day','https://www.givewell.org/sources/blog-post/our-recommendations-for-giving-in-2020#2',
  /* donation_proceess */ 'GiveWell looked at the funding gap and value of marginal funds for each of its top charities. The decision to allocate these funds happened shortly after the annual top charity refresh and the updated recommendations https://www.givewell.org/charities/top-charities/2019/open-philanthropy-recommendation#Our_recommended_allocation_to_Open_Philanthropy to Good Ventures (via Open Philanthropy) on how much annual support to give to each top charity. It therefore took into account the amounts already recommended to Open Philanthropy, and calculated the best use of funds at the margin after that.',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'Grant to support the Malaria Consortium''s Seasonal Malaria Chemoprevention (SMC) program. https://www.givewell.org/charities/top-charities/2020/open-philanthropy-recommendation#Malaria_Consortium-s_seasonal_malaria_chemoprevention_program breaks down the programs funded by this money plus $27 million from Open Philanthropy: (1) "Extend its funding runway for its current programs in Burkina Faso, Chad, Nigeria, and Togo through 2022 ($20.8 million) at the scale Malaria Consortium expects to achieve in 2021." (2) "Expand to newly-eligible states or local government areas (LGAs) in Nigeria in 2022 and maintain work in those new areas in 2023 ($7.8 million). We estimate that the cost-effectiveness of SMC in Nigeria is 14x cash." (3) "Put $2.2 million toward continuing its work in 2023."',
  /* intended_funding_timeframe_in_months */ NULL,
  /* donor_donee_reason */ 'https://www.givewell.org/sources/blog-post/our-recommendations-for-giving-in-2020#2 says: "We decided where to allocate the Maximum Impact Fund donations at the same time as we made our recommendation to Open Philanthropy. We decided to allocate Maximum Impact Fund donations to Malaria Consortium''s SMC program because it was the highest priority gap after we accounted for our recommendation to Open Philanthropy. However, we could have instead chosen to allocate them to the highest priority gap before our recommendation to Open Philanthropy was accounted for, Helen Keller International''s vitamin A supplementation program, since our Maximum Impact Fund decision and Open Philanthropy recommendation were made at the same time. In each case, the overall effect would be the same [...]."',
  /* donor_amount_reason */ 'The entirety of funds available in the Maximum Impact Fund from Q3 2020 was granted to Malaria Consortium, as it was the highest-priority funding need identified.',
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q3 2020 (July to September) and would therefore be expected to be in Q4 2020, which it is. The decision process for this quarter is combined with the grant recommendations to Open Philanthropy to recommend to Good Ventures.',
  /* donor_next_donation_thoughts */ NULL,
  /* donor_retrospective */ NULL,
  /* notes */ NULL),

  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',25900000,'2021-03-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','GiveWell',25900000,1.0,'Nigeria|Democratic Republic of the Congo',NULL,'2021-06-24','day','https://www.givewell.org/maximum-impact-fund/grants-jan-feb-2021#Against_Malaria_Foundation',
  /* donation_process */ 'This grant was decided along with several other grant decisions and funding recommendations made in January and Febuary 2021 that https://www.givewell.org/maximum-impact-fund/grants-jan-feb-2021 documents; the Malaria Consortium also received a large sum of money as part of the process but via Open Philanthropy.',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'Grant "to support its work in Nigeria in 2021-22 ($21.4 million) and in DRC in 2022-23 ($5.9 million)."',
  /* intended_funding_timeframe_in_months */ NULL,
  /* donor_donee_reason */ 'https://www.givewell.org/maximum-impact-fund/grants-jan-feb-2021#Case_for_these_grants gives estimates of AMF''s work in Nigeria as 15x cash and Congo as 13x cash. It identifies the Nigeria opportunity as time-sensitive, and the Congo opportunity as potentially time-sensitive. It also reports having completed a review of monitoring results of AMF''s Congo distribution, and being satisfied with the results.',
  /* donor_amount_reason */ 'The entire amount of funds donated to the GiveWell Maximum Impact Fund for Q4 2020 was granted to AMF. The amount in Q4 is generally higher than in other quarters due to greater amounts of giving during Giving Season.',
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q4 2020 (October to December) and would therefore be expected to be in Q1 2021, which it is. The decision process for this quarter is combined with the grant recommendations to Open Philanthropy to recommend to Good Ventures.',
  /* donor_next_donation_thoughts */ NULL,
  /* donor_retrospective */ NULL,
  /* notes */ 'Some other grants to AMF are also recommended alongside this: a total of about $1.5 million from Effective Altruism Funds ($0.7 million), Effective Altruism Australia ($0.3 million), Effektiv Spenden ($0.4 million), and RC Forward ($0.1 million), each of which offer their own version of the Maximum Impact Fund. In addition, GiveWell suggested to a separate donor to donate $20 million to AMF.'),

  ('GiveWell Maximum Impact Fund','Helen Keller International',11000000,'2021-06-01','month','donation log','Global health/nutrition/vitamin A supplementation','https://www.givewell.org/maximum-impact-fund','GiveWell',13500000,0.8148,'Cameroon|Nigeria',NULL,'2021-08-31','day','https://www.givewell.org/maximum-impact-fund/allocation-q1-2021',
  /* donation_process */ 'https://www.givewell.org/maximum-impact-fund/allocation-q1-2021#How_did_we_arrive_at_our_allocation explains the seven principles followed in deciding the allocation: "Principle 1: Put significant weight on our cost-effectiveness estimates. Principle 2: Consider additional information that we have not explicitly modeled about an organization. Principle 3: Consider additional information that we have not explicitly modeled about a funding gap. Principle 4: Assess charities'' funding gaps at the margin, i.e., how they would spend additional funding, where possible. Principle 5: Default to not imposing restrictions on charities'' spending. Principle 6: Default to funding on a three-year horizon, modifying to preserve our options for the future where doing so is low-cost. Principle 7: Ensure charities are incentivized to engage with our process." There are more details in the document.',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'The grant page says: "$3.5 million will fund VAS campaigns in Cameroon in the second half of 2021 through the first half of 2024. $7.5 million will fund VAS campaigns in Nigeria in the second half of 2021 through the end of 2024."',
  /* intended_funding_timeframe_in_months */ 42,
  /* donor_donee_reason */ 'The grant page https://www.givewell.org/maximum-impact-fund/allocation-q1-2021#Helen_Keller_International has "Case for the grant" sections for both the Nigeria and Cameroon grants. Estimates for cost-effectiveness were 24x cash for Nigeria (with an uncertainty and a lower estimate of 8x cash) and 28x for Cameroon. There are more details on te grant page.',
  /* donor_amount_reason */ 'The amount matches the intended use of funds: "$3.5 million will fund VAS campaigns in Cameroon in the second half of 2021 through the first half of 2024. $7.5 million will fund VAS campaigns in Nigeria in the second half of 2021 through the end of 2024." It does not use up the entirety of available funds for granting; an additional $2.5 million is granted to other grantees.',
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q1 2021 (January to March) and would therefore be expected to be in Q2 2021, which it is.',
  /* donor_next_donation_thoughts */ NULL,
  /* donor_retrospective */ NULL,
  /* notes */ NULL),

  ('GiveWell Maximum Impact Fund','Sightsavers',1500000,'2021-06-01','month','donation log','Global health/nutrition/vitamin A supplementation','https://www.givewell.org/maximum-impact-fund','GiveWell',13500000,0.1111,'Chad',NULL,'2021-08-31','day','https://www.givewell.org/maximum-impact-fund/allocation-q1-2021',
  /* donation_process */ 'https://www.givewell.org/maximum-impact-fund/allocation-q1-2021#How_did_we_arrive_at_our_allocation explains the seven principles followed in deciding the allocation: "Principle 1: Put significant weight on our cost-effectiveness estimates. Principle 2: Consider additional information that we have not explicitly modeled about an organization. Principle 3: Consider additional information that we have not explicitly modeled about a funding gap. Principle 4: Assess charities'' funding gaps at the margin, i.e., how they would spend additional funding, where possible. Principle 5: Default to not imposing restrictions on charities'' spending. Principle 6: Default to funding on a three-year horizon, modifying to preserve our options for the future where doing so is low-cost. Principle 7: Ensure charities are incentivized to engage with our process." There are more details in the document.',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'Grant "to partially fund deworming MDA in 2022-2024 in six regions of Chad that it has classified as "Priority 1" regions."',
  /* intended_funding_timeframe_in_months */ 36,
  /* donor_donee_reason */ 'https://www.givewell.org/maximum-impact-fund/allocation-q1-2021#Sightsavers has a "Case for the grant" section that estimates the cost-effectiveness of the grant as 14x cash. It includes more details, and also talks about Priority 2 regions that were ultimately not funded by the grant.',
  /* donor_amount_reason */ 'The amount only partially funds the programs it funds; it covers $1.5 million out of $13.5 million available for granting. The exact reasons for allocating this particular amount to this grantee are not described.',
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q1 2021 (January to March) and would therefore be expected to be in Q2 2021, which it is.',
  /* donor_next_donation_thoughts */ NULL,
  /* donor_retrospective */ NULL,
  /* notes */ NULL),

  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',1000000,'2021-06-01','month','donation log','Global health/nutrition/vitamin A supplementation','https://www.givewell.org/maximum-impact-fund','GiveWell',13500000,0.0741,'Chad',NULL,'2021-08-31','day','https://www.givewell.org/maximum-impact-fund/allocation-q1-2021',
  /* donation_process */ 'https://www.givewell.org/maximum-impact-fund/allocation-q1-2021#How_did_we_arrive_at_our_allocation explains the seven principles followed in deciding the allocation: "Principle 1: Put significant weight on our cost-effectiveness estimates. Principle 2: Consider additional information that we have not explicitly modeled about an organization. Principle 3: Consider additional information that we have not explicitly modeled about a funding gap. Principle 4: Assess charities'' funding gaps at the margin, i.e., how they would spend additional funding, where possible. Principle 5: Default to not imposing restrictions on charities'' spending. Principle 6: Default to funding on a three-year horizon, modifying to preserve our options for the future where doing so is low-cost. Principle 7: Ensure charities are incentivized to engage with our process." There are more details in the document.',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'Grant "to fund long-lasting insecticide-treated net (LLIN) distributions in the Democratic Republic of the Congo (DRC) in 2023, [...] We estimate that AMF''s room for more funding for DRC in 2023 is about $2.9 million [...] Therefore, we believe the actual effect of this grant will be to free up $1 million of AMF''s future revenue to use for other LLIN campaigns."',
  /* intended_funding_timeframe_in_months */ NULL,
  /* donor_donee_reason */ 'https://www.givewell.org/maximum-impact-fund/allocation-q1-2021#Against_Malaria_Foundation estimates the grant as 15x cash, along with a range of estimates depending on how thte funds end up funging (15x for Nigeria, 9x for Togo, 17x for Uganda).',
  /* donor_amount_reason */ 'The amount only partially funds the programs it funds ($1 million out of $2.9 million); it covers $1 million out of $13.5 million available for granting. The exact reasons for allocating this particular amount to this grantee are not described.',
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q1 2021 (January to March) and would therefore be expected to be in Q2 2021, which it is.',
  /* donor_next_donation_thoughts */ NULL,
  /* donor_retrospective */ NULL,
  /* notes */ NULL),

  ('GiveWell Maximum Impact Fund','New Incentives',9400000,'2021-08-01','month','donation log','Cash transfers/conditional cash transfers','https://www.givewell.org/maximum-impact-fund','GiveWell',14000000,0.6714,'Nigeria',NULL,'2012-12-02','day','https://www.givewell.org/maximum-impact-fund/allocation-q2-2021',
  /* donation_process */ 'The grant page lists seven principles followed in the grant allocation: "Principle 1: Put significant weight on our cost-effectiveness estimates. Principle 2: Consider additional information that we have not explicitly modeled about an organization. Principle 3: Consider additional information that we have not explicitly modeled about a funding gap. Principle 4: Assess charities'' funding gaps at the margin, i.e., how they would spend additional funding, where possible. Principle 5: Default to not imposing restrictions on charities'' spending. Principle 6: Default to funding on a three-year horizon, modifying to preserve our options for the future where doing so is low-cost. Principle 7: Ensure charities are incentivized to engage with our process."',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'Grant "to fund the scale-up of its conditional cash transfers for infant immunization program in North West Nigeria in 2021 and to maintain the program at that scale through 2023." https://www.givewell.org/maximum-impact-fund/allocation-q2-2021#How_we_expect_this_grant_will_be_used says: "This $9.4 million grant is intended to cover New Incentives'' operating costs for the additional 18 LGAs from the time of expansion in 2021 through 2023. This expansion will allow New Incentives to increase the total number of infants enrolled in the program in 2021-2023 from an estimated 600,000 to an estimated 1.1 million, covering roughly 45% of the total infants in the three Nigerian states in which the program operates: Jigawa, Katsina, and Zamfara."',
  /* intended_funding_timeframe_in_months */ 29,
  /* donor_donee_reason */ 'This is a followup to a grant https://www.openphilanthropy.org/focus/global-health-and-development/miscellaneous/new-incentives-general-support-2021 made by Open Philanthropy. https://www.givewell.org/maximum-impact-fund/allocation-q2-2021#How_we_expect_this_grant_will_be_used says: "Since receiving that grant, New Incentives has been able to expand its program more quickly than anticipated. [...] New Incentives told us that without this additional funding, it would not be able to expand its program beyond the initial 17 LGAs in 2021, and program expansion would pause in July 2021." The potential scale-up possible with the grant was the main reason for donating.',
  /* donor_amount_reason */ 'The amount is based on the total available amount for granting ($14 million) and the size of the need for New Incentives'' program, per the seven principles of grant allocation used.',
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q2 2021 (April to June) and would therefore be expected to be in Q3 2021, which it is.',
  /* donor_next_donation_thoughts */ NULL,
  /* donor_retrospective */ NULL,
  /* notes */ 'While the write-ups for previous grant rounds were done as blog posts, the write-up for this grant round is published as a separate page. It is also delayed to over three months after the grant.'),

  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',2300000,'2021-08-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','GiveWell',14000000,0.1643,'Togo|Uganda|Democratic Republic of the Congo|Nigeria',NULL,'2012-12-02','day','https://www.givewell.org/maximum-impact-fund/allocation-q2-2021',
  /* donation_process */ 'https://www.givewell.org/maximum-impact-fund/allocation-q1-2021#How_did_we_arrive_at_our_allocation explains the seven principles followed in deciding the allocation: "Principle 1: Put significant weight on our cost-effectiveness estimates. Principle 2: Consider additional information that we have not explicitly modeled about an organization. Principle 3: Consider additional information that we have not explicitly modeled about a funding gap. Principle 4: Assess charities'' funding gaps at the margin, i.e., how they would spend additional funding, where possible. Principle 5: Default to not imposing restrictions on charities'' spending. Principle 6: Default to funding on a three-year horizon, modifying to preserve our options for the future where doing so is low-cost. Principle 7: Ensure charities are incentivized to engage with our process." There are more details in the document.',
  /* intended_use_of_funds_category */ 'Organizational general support',
  /* intended_use_of_funds */ 'https://www.givewell.org/maximum-impact-fund/allocation-q2-2021#How_we_expect_this_grant_will_be_used-0 says: "The funding opportunities AMF is considering supporting are: (1) Purchasing additional LLINs to be delivered in nationwide campaigns in Togo and Uganda. (2) Filling the remaining funding gap for LLIN distributions in the Democratic Republic of the Congo (DRC). (3) Shortening the length of time that passes between LLIN distributions in three Nigerian states where distributions are currently supported by PMI."',
  /* intended_funding_timeframe_in_months */ NULL,
  /* donor_donee_reason */ 'https://www.givewell.org/maximum-impact-fund/allocation-q2-2021#amfcase says: "AMF''s overall portfolio is cost-effective. We estimate that the opportunities listed above are above our cost-effectiveness threshold: DRC (13x cash), Nigeria (15x cash), Togo (9x cash), and Uganda (17x cash).36 For DRC and Nigeria, these estimates include our recent work to model the cost-effectiveness of reducing the amount of time that passes between LLIN distributions. [...] Instead, we''re proposing this grant based on the third principle for maximizing cost-effectiveness over time: we are recommending this grant because we have a sufficiently high degree of certainty that a contribution to AMF''s overall portfolio is above our cost-effectiveness threshold."',
  /* donor_amount_reason */ 'The amount is determined by the total amount available ($14 million) and the $9.4 million already granted to New Incentives for a more time-sensitive need. The remaining amount ($4.6 million) is split equally between AMF and Malaria Consortium, both of which have substantial room for more funding that is similarly cost-effective but not time-sensitive.',
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q2 2021 (April to June) and would therefore be expected to be in Q3 2021, which it is.',
  /* donor_next_donation_thoughts */ 'https://www.givewell.org/maximum-impact-fund/allocation-q2-2021#amfcase says: "AMF has much more room for more funding above our cost-effectiveness threshold than will be filled by this grant. We consequently expect to direct much more funding to it in 2021. [...] We expect to do more work to refine our estimates of AMF''s cost-effectiveness and room for more funding, which will inform the total amount of funding we ultimately direct to AMF this year."',  
  /* donor_retrospective */ 'The fund allocation for Q3 2021 allocates the entire $8.7 million for that quarter to AMF, suggesting a continued positive evaluation of AMF''s work. As of December 2021, no write-up on the grant has been published.',
  /* notes */ 'https://www.givewell.org/maximum-impact-fund/allocation-q2-2021#amfcase describes some risks and reservations about the grant.'),

  ('GiveWell Maximum Impact Fund','Malaria Consortium',2300000,'2021-08-01','month','donation log','Global health/malaria/seasonal malaria chemoprevention','https://www.givewell.org/maximum-impact-fund','GiveWell',14000000,0.1643,'Burkina Faso|Nigeria|Togo',NULL,'2012-12-02','day','https://www.givewell.org/maximum-impact-fund/allocation-q2-2021',
  /* donation_process */ 'https://www.givewell.org/maximum-impact-fund/allocation-q1-2021#How_did_we_arrive_at_our_allocation explains the seven principles followed in deciding the allocation: "Principle 1: Put significant weight on our cost-effectiveness estimates. Principle 2: Consider additional information that we have not explicitly modeled about an organization. Principle 3: Consider additional information that we have not explicitly modeled about a funding gap. Principle 4: Assess charities'' funding gaps at the margin, i.e., how they would spend additional funding, where possible. Principle 5: Default to not imposing restrictions on charities'' spending. Principle 6: Default to funding on a three-year horizon, modifying to preserve our options for the future where doing so is low-cost. Principle 7: Ensure charities are incentivized to engage with our process." There are more details in the document.',
  /* intended_use_of_funds_category */ 'Direct project expenses',
  /* intended_use_of_funds */ 'https://www.givewell.org/maximum-impact-fund/allocation-q2-2021#How_we_expect_this_grant_will_be_used-3 says: "We estimate that Malaria Consortium has room for more funding of about $100 million for SMC campaigns in 2022-24.40 Roughly $75 million of this total would be used to maintain its programs at their current scale (i.e., to reach a similarly sized target population of children as will be reached in 2021, after accounting for annual population growth) in Burkina Faso, Nigeria, and Togo in 2023-24. [...] We expect that Malaria Consortium will use this grant to support one or multiple of these opportunities, but we are uncertain which activities in particular this funding will enable. Our understanding is that maintaining these programs at their current scale is Malaria Consortium''s top priority for additional funding."',
  /* intended_funding_timeframe_in_months */ NULL,
  /* donor_donee_reason */ 'https://www.givewell.org/maximum-impact-fund/allocation-q2-2021#mccase says: "Instead, we''re proposing this grant based on the third principle for maximizing cost-effectiveness over time: we are recommending this grant because we have a sufficiently high degree of certainty that a contribution to Malaria Consortium''s overall portfolio is above our cost-effectiveness threshold."',
  /* donor_amount_reason */ 'The amount is determined by the total amount available ($14 million) and the $9.4 million already granted to New Incentives for a more time-sensitive need. The remaining amount ($4.6 million) is split equally between AMF and Malaria Consortium, both of which have substantial room for more funding that is similarly cost-effective but not time-sensitive.',
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q2 2021 (April to June) and would therefore be expected to be in Q3 2021, which it is.',
  /* donor_next_donation_thoughts */ 'https://www.givewell.org/maximum-impact-fund/allocation-q2-2021#mccase says: "Malaria Consortium has much more room for more funding above our cost-effectiveness threshold than will be filled by this grant. We consequently expect to direct much more funding to it in 2021. [...] We expect to do more work to refine our estimates of Malaria Consortium''s cost-effectiveness and room for more funding, which will inform the total amount of funding we ultimately direct to Malaria Consortium this year."',
  /* donor_retrospective */ NULL,
  /* notes */ 'https://www.givewell.org/maximum-impact-fund/allocation-q2-2021#mcrisks describes some risks and reservations about the grant.'),

  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',8700000,'2021-11-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','GiveWell',8700000,1.0,NULL,NULL,NULL,NULL,NULL,
  /* donation_process */ NULL,
  /* intended_use_of_funds_category */ 'Organizational general support',
  /* intended_use_of_funds */ NULL,
  /* intended_funding_timeframe_in_months */ NULL,
  /* donor_donee_reason */ NULL,
  /* donor_amount_reason */ NULL,
  /* donor_timing_reason */ 'This discretionary regrant is done for each quarter, usually within 2 to 3 months of the end of the quarter. This particular grant is for Q3 2021 (July to September) and would therefore be expected to be in Q4 2021, which it is.',
  /* donor_next_donation_thoughts */ NULL,
  /* donor_retrospective */ NULL,
  /* notes */ NULL);

/* Old format grants */
insert into donations(donor, donee, amount, donation_date, donation_date_precision, donation_date_basis, cause_area, url, notes, affected_countries, goal_amount, fraction, influencer) values
  ('GiveWell Maximum Impact Fund','Malaria Consortium',1100000,'2018-11-01','month','donation log','Global health/malaria/seasonal malaria chemoprevention','https://www.givewell.org/maximum-impact-fund','See https://blog.givewell.org/2018/11/26/our-updated-top-charities-for-giving-season-2018/ for more detail. Grant uses money donated between July and September 2018 (i.e., Q3 2018) of $1.1 million. The entire amount was donated to Malaria Consortium because that was identified by GiveWell at the time as the charity with the most pressing funding gap to fill',NULL,1100000,1.0,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',2870000,'2018-08-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','See https://blog.givewell.org/2018/08/28/allocation-of-discretionary-funds-from-q2-2018/ for more detail. Grant uses money donated between April and June 2018 (i.e., Q2 2018) of $1.2 million, as well as $2.9 million of unrestricted funds ($1.8 million held in reserve, and $1.1 million from a single donor donating $2.1 million). 70% of this total of $4.1 million is allocated to AMF in line with the general recommendation to donors to give 70% to AMF and 30% to SCI',NULL,4100000,0.7,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Schistosomiasis Control Initiative',1230000,'2018-08-01','month','donation log','Global health/deworming','https://www.givewell.org/maximum-impact-fund','See https://blog.givewell.org/2018/08/28/allocation-of-discretionary-funds-from-q2-2018/ for more details. Grant uses money donated between April and June 2018 (i.e., Q2 2018) of $1.2 million, as well as $2.9 million of unrestricted funds ($1.8 million held in reserve, and $1.1 million from a single donor donating $2.1 million). 30% of this total of $4.1 million is allocated to SCI in line with the general recommendation to donors to give 70% to AMF and 30% to SCI',NULL,4100000,0.3,'GiveWell'),  
  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',2072000,'2018-05-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between January and March 2018 (i.e., Q1 2018). See https://blog.givewell.org/2018/06/04/allocation-of-discretionary-funds-from-q1-2018/ for more details. Note that the grantmaking page rounds the total to $3.0 million, but the blog post specifies the amount as $2.96 million; we are using 70% of the latter',NULL,2960000,0.7,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Schistosomiasis Control Initiative',888000,'2018-05-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between January and March 2018 (i.e., Q1 2018). See https://blog.givewell.org/2018/06/04/allocation-of-discretionary-funds-from-q1-2018/ for more details. Note that the grantmaking page rounds the total to $3.0 million, but the blog post specifies the amount as $2.96 million; we are using 30% of the latter',NULL,2960000,0.3,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Schistosomiasis Control Initiative',5600000,'2018-03-01','month','donation log','Global health/deworming','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between October and December 2017 (i.e., Q4 2017). See https://blog.givewell.org/2018/04/06/allocation-of-discretionary-funds-from-q4-2017/ for more details',NULL,5600000,1.0,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Deworm the World Initiative',700000,'2017-11-27','day','date of donation announcement','Global health/deworming','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between July and September 2017. See https://blog.givewell.org/2017/11/27/our-top-charities-for-giving-season-2017/ for more details. This is part of $15.9 million GiveWell is attempting to allocate to Deworm the World Initiative; the remaining $15.2 million will come from Good Ventures','India|Kenya',700000,1.0,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Deworm the World Initiative',2250000,'2017-08-30','day','date of donation announcement','Global health/deworming','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between January and June 2017. Blog post https://blog.givewell.org/2017/08/30/why-were-allocating-discretionary-funds-to-the-deworm-the-world-initiative/ announces $2.25 million in made and planned grants to Deworm the World Initiative from funds given to GiveWell to regrant at its discretion (see https://blog.givewell.org/2016/12/19/discretionary-grant-making-and-implications-for-donor-agency/ for more background on how this differs from GiveWell top charities). This is the entirety of the money being granted or considered for granting at this time; the blog post explains why the grant is being made to Deworm the World Initiative even though GiveWell continues to recommend Against Malaria Foundation as the top charity that donors should allocate 100% of their donations to. Amount includes $1.25 million already granted and an additional $1 million that is planned for granting in the next month or two',NULL,2250000,1.0,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',2500000,'2017-08-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between January and February 2017. Blog post https://blog.givewell.org/2017/04/03/allocation-of-discretionary-funds/ announces $4.4 million grant to AMF from the funds GiveWell has for discretionary regranting (see https://blog.givewell.org/2016/12/19/discretionary-grant-making-and-implications-for-donor-agency/ for more background on how this differs from GiveWell top charities). This is because AMF has the largest remaining Execution Level 1 gap based on the funding gaps identified in November 2016, and reports of funds raised as of February 2017. An additional $0.5 million is being granted to Deworm the World Initiative, and GiveWell recommends that donors giving now should donate all their money to the Against Malaria Foundation. Although a total grant of $4.4 million is announced, only $2.1 million is allocated at the time. The remaining $2.5 million (a bit more than the original estimate would suggest) for donations between January and February 2017 is paid out in August 2017',NULL,4900000,0.510,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',2100000,'2017-04-03','day','date of donation announcement','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between October and December 2016. Blog post https://blog.givewell.org/2017/04/03/allocation-of-discretionary-funds/ announces $4.4 million grant to AMF from the funds GiveWell has for discretionary regranting (see https://blog.givewell.org/2016/12/19/discretionary-grant-making-and-implications-for-donor-agency/ for more background on how this differs from GiveWell top charities). This is because AMF has the largest remaining Execution Level 1 gap based on the funding gaps identified in November 2016, and reports of funds raised as of February 2017. An additional $0.5 million is being granted to Deworm the World Initiative, and GiveWell recommends that donors giving now should donate all their money to the Against Malaria Foundation. Although a total grant of $4.4 million is announced, only $2.1 million out of that is allocated at this time; the rest would be granted in April',NULL,4900000,0.429,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Deworm the World Initiative',500000,'2017-04-03','day','date of donation announcement','Global health/deworming','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between October and December 2016. Blog post https://blog.givewell.org/2017/04/03/allocation-of-discretionary-funds/ announces $0.5 million to Deworm the World Initiative from the funds GiveWell has for discretionary regranting (see https://blog.givewell.org/2016/12/19/discretionary-grant-making-and-implications-for-donor-agency/ for more background on how this differs from GiveWell top charities), to fill most of an unfilled $0.53 million Execution Level 2 funding gap. This is out of a total of $4.9 million in granted money (the remaining $4.4 million went to the Against Malaria Foundation, with the highest priority of funding gap). The funding to Deworm the World Initiative was decided over other alternatives, including Schistosomiasis Control Initiative, the END Fund, GiveDirectly, Malaria Consortium, and Sightsavers',NULL, 4900000, 0.102,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',500000,'2016-12-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between July and September 2016', NULL, 500000, 1.0,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',300000,'2016-09-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between May and June 2016', NULL, 300000, 1.0,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',200000,'2016-06-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between March and April 2016', NULL, 200000, 1.0,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',1000000,'2016-04-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between January and February 2016', NULL, 1000000, 1.0,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',1600000,'2016-02-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','Grant uses money donated in December 2015', NULL, 1600000, 1.0,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',800000,'2016-01-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between October and November 2015', NULL, 800000, 1.0,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',600000,'2015-12-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between June and September 2015', NULL, 600000, 1.0,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',667000,'2015-07-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between January and May 2015', NULL, 1000000, 0.667,'GiveWell'),
  ('GiveWell Maximum Impact Fund','GiveDirectly',133000,'2015-07-01','month','donation log','Cash transfers/unconoditional cash transfers','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between January and May 2015', NULL, 1000000, 0.133,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Schistosomiasis Control Initiative',133000,'2015-07-01','month','donation log','Global health/deworming','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between January and May 2015', NULL, 1000000, 0.133,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Deworm the World Initiative',67000,'2015-07-01','month','donation log','Global health/deworming','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between January and May 2015', NULL, 1000000, 0.067,'GiveWell'),

  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',1467400,'2015-03-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between November and December 2014', NULL, 2200000, 0.667,'GiveWell'),
  ('GiveWell Maximum Impact Fund','GiveDirectly',292600,'2015-03-01','month','donation log','Cash transfers/unconoditional cash transfers','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between November and December 2014', NULL, 2200000, 0.133,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Schistosomiasis Control Initiative',292600,'2015-03-01','month','donation log','Global health/deworming','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between November and December 2014', NULL, 2200000, 0.133,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Deworm the World Initiative',147400,'2015-03-01','month','donation log','Global health/deworming','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between November and December 2014', NULL, 2200000, 0.133,'GiveWell'),

  ('GiveWell Maximum Impact Fund','Against Malaria Foundation',66700,'2015-01-01','month','donation log','Global health/malaria/bednets','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between July and October 2014',NULL,100000,0.667,'GiveWell'),
  ('GiveWell Maximum Impact Fund','GiveDirectly',13300,'2015-01-01','month','donation log','Cash transfers/unconoditional cash transfers','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between July and October 2014',NULL,100000,0.133,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Schistosomiasis Control Initiative',13300,'2015-01-01','month','donation log','Global health/deworming','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between July and October 2014',NULL,100000,0.133,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Deworm the World Initiative',6700,'2015-01-01','month','donation log','Global health/deworming','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between July and October 2014',NULL,100000,0.067,'GiveWell'),

  ('GiveWell Maximum Impact Fund','GiveDirectly',60000,'2014-08-01','month','donation log','Cash transfers/unconoditional cash transfers','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between April and June 2014',NULL,100000,0.6,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Schistosomiasis Control Initiative',20000,'2014-08-01','month','donation log','Global health/deworming','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between April and June 2014',NULL,100000,0.2,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Deworm the World Initiative',20000,'2014-08-01','month','donation log','Global health/deworming','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between April and June 2014',NULL,100000,0.2,'GiveWell'),
  
  ('GiveWell Maximum Impact Fund','GiveDirectly',110000,'2014-05-01','month','donation log','Cash transfers/unconoditional cash transfers','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between January and March 2014',NULL,200000,0.55,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Schistosomiasis Control Initiative',80000,'2014-05-01','month','donation log','Global health/deworming','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between January and March 2014',NULL,200000,0.4,'GiveWell'),
  ('GiveWell Maximum Impact Fund','Deworm the World Initiative',10000,'2014-05-01','month','donation log','Global health/deworming','https://www.givewell.org/maximum-impact-fund','Grant uses money donated between January and March 2014',NULL,200000,0.05,'GiveWell');


